Roden, M., Merker, L., Christiansen, A. V., Roux, F., Salsali, A., Kim, G., . . . Broedl, U. C. (2015). Safety, tolerability and effects on cardiometabolic risk factors of empagliflozin monotherapy in drug-naïve patients with type 2 diabetes: A double-blind extension of a Phase III randomized controlled trial. Cardiovasc Diabetol.

Roden, Michael, Ludwig Merker, Anita Vedel Christiansen, Flavien Roux, Afshin Salsali, Gabriel Kim, Peter Stella, Hans J. Woerle, و Uli C. Broedl. "Safety, Tolerability and Effects On Cardiometabolic Risk Factors of Empagliflozin Monotherapy in Drug-naïve Patients With Type 2 Diabetes: A Double-blind Extension of a Phase III Randomized Controlled Trial." Cardiovasc Diabetol 2015.

Roden, Michael, et al. "Safety, Tolerability and Effects On Cardiometabolic Risk Factors of Empagliflozin Monotherapy in Drug-naïve Patients With Type 2 Diabetes: A Double-blind Extension of a Phase III Randomized Controlled Trial." Cardiovasc Diabetol 2015.